Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06126588
Title Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial (ELUMEN)
Acronym ELUMEN
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Central Hospital, Nancy, France
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.